Tag: Drug development

April 22, 2026

Title: Roche’s Fenebrutinib Shows Promise in MS Trials — But Safety Concerns Loom Ahead of FDA Review

April 19, 2026

New KRAS Inhibitors Transform Pancreatic Cancer Treatment

April 18, 2026

Record Biotech IPO and the Future of Obesity Drugs Beyond GLP-1

April 17, 2026

Integrating Animal, Human, and AI Models in Translational Research

April 15, 2026

KCNT1-Targeting Antisense Oligonucleotide Reduces Seizures but Causes Hydrocephalus

April 14, 2026

Ben Sasse Praises Revolution Medicines Pancreatic Cancer Pill for Extending Life

April 13, 2026

Biotech Update: Revolution Medicines, GSK and Spyre Therapeutics Latest News

April 10, 2026

FDA Rejects Replimune’s Experimental Skin Cancer Treatment Again

April 10, 2026

CAR-T Therapy Gains in Autoimmune Disease and FDA Withdraws GSK Leucovorin

April 9, 2026

Senate Democrats Propose Framework to Control Health Care Costs